Scinai Immunotherapeutics completed a private placement raising approximately $4 million before fees, issuing 2.46 million American Depositary Shares and warrants. The proceeds will support advancing current customer programs, expanding its contract development and manufacturing organization (CDMO), and investing selectively in its immunotherapy pipeline. The company expects its cash runway to extend into late 2027 or possibly 2028, depending on customer orders and successful execution of its plans. This financing strengthens Scinai's ability to execute on growth opportunities and develop its therapeutic platform further.
Scinai Immunotherapeutics' recent $4.0 million financing provides context for the health sector's varied performance on Pluang. For readers following health-sector US stocks, here is Pluang's market snapshot as of Oct 16, 2026 19:01 WIB: out of 150 stocks, 93 rose and 46 fell. Among notable movers, FLNA traded at USD 0.73 with a 1-day change of -3.76% and a near-even Pluang order split, HRTX rose 3.05% to USD 0.39 despite 60% sell orders, and MRVI stood at USD 6.91 with a 1-day decline of 2.26%.
Nasdaq announced that trading in CN Healthy Food Tech Group Corp.'s common stock and warrants will resume on October 19, 2026, after being halted since October 1, 2025. The resumption marks the end of a year-long trading suspension, allowing investor...
David Solomon, CEO of Goldman Sachs, has been appointed as the new chair of The Business Council, taking over from Brian Cornell, Executive Chair of Target Corporation. This leadership change comes at a critical time as the Council addresses challeng...
SEDA Experts LLC has appointed Noor Ul Islam as Managing Director, enhancing its capabilities in risk management and securities practices. With nearly 30 years of experience at major financial institutions like Citibank and Barclays, Islam brings dee...
The global pharmaceutical market is projected to grow from USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, expanding at a CAGR of 6.15%. Growth is fueled by advances in biologics, AI-driven drug discovery, specialty drugs, and manufacturing i...
The Out of Home Advertising Association of America (OAAA) held the 84th Annual OBIE Awards in New York City, celebrating the best creative campaigns in out of home (OOH) advertising. Paramount was inducted into the OBIE Hall of Fame for its longstand...
